Capricor Therapeutics, Inc. (CAPR)
28.18
+0.27
(+0.97%)
USD |
NASDAQ |
Feb 25, 10:56
Capricor Therapeutics Research and Development Expense (Quarterly) : 20.11M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 12.30M |
| Agenus, Inc. | 23.60M |
| Curis, Inc. | 6.432M |
| LadRx Corp. | 0.0288M |
| Plus Therapeutics, Inc. | 2.436M |